PDE10-IN-1

CAS No. 1516896-09-5

PDE10-IN-1( —— )

Catalog No. M20167 CAS No. 1516896-09-5

PDE10-IN-1 is PDE10-IN-1 inhibitor extracted from Patent WO 2013192273 A1 for treating CNS and metabolic disorders.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 177 In Stock
5MG 312 In Stock
10MG 447 In Stock
25MG 714 In Stock
50MG 1017 In Stock
100MG 1368 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PDE10-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    PDE10-IN-1 is PDE10-IN-1 inhibitor extracted from Patent WO 2013192273 A1 for treating CNS and metabolic disorders.
  • Description
    PDE10-IN-1 is PDE10-IN-1 inhibitor extracted from Patent WO 2013192273 A1 for treating CNS and metabolic disorders.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    PDE10
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1516896-09-5
  • Formula Weight
    350.42
  • Molecular Formula
    C23H18N4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:2 mg/mL?(5.41 mM)
  • SMILES
    Cc1c(nc2c3cccnc3ccn12)[C@@H]1C[C@H]1c1nc2c(C)ncc(C)n2n1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Campbell John Emmerson et al. Preparation of heteroaryl compounds as PDE-10 inhibitors for treating CNS and metabolic disorders. Patent WO 2013192273 A1 20131227.
molnova catalog
related products
  • Lotamilast

    Lotamilast (RVT 501, E6005) is a?potent, selective PDE4 inhibitor with IC50 of 2.8 nM, suppresses the production of various cytokines from human lymphocytes and monocytes with IC50 of 0.49-3.1 nM.

  • Cilomilast

    A potent and selective PDE4 inhibitor with IC50 of 95/120 nM for LPDE4/HPDE4.

  • cis-Tadalafil

    cis-Tadalafil (cis-IC-351) is a potent PDE5 inhibitor with an IC50 value of 0.09 μM that can be used to study arterial hypertension.